JAMP DARIFENACIN
Identification of Jamp Darifenacin
| No description |
Google image searchProduct monograph
Active ingredient
darifenacin (darifenacin hydrobromide), 7.5 MG
DIN: 02491869
Dosage form(s): TABLET (EXTENDED-RELEASE)
Route(s) of administration: ORAL
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 24-DEC-2021
ATC:
- G04 — UROLOGICALS (ATC, ATC/DDD, )
- G04B — OTHER UROLOGICALS, INCL. ANTISPASMODICS (ATC, ATC/DDD)
- G04BD — Urinary antispasmodics (ATC, ATC/DDD)
- G04BD10 — DARIFENACIN (ATC/DDD)
Reference brand drug: Enablex
